Dr. Holliday is an Advanced Postdoctoral Research Fellow, Dr. Monteith is a Clinical Research Psychologist, and Dr. Wortzel is the Co-Director of the Suicide Risk Management Consultation Program and Director of Neuropsychiatric Services, all at the Rocky Mountain Mental Illness Research, Education and Clinical Center for Suicide Prevention in Denver. Dr. Holliday is an Instructor, Dr. Monteith is an Assistant Professor, and Dr. Wortzel is Associate Professor, all at the University of Colorado Anschutz Medical Campus in Aurora, in Colorado. Correspondence: Dr. Holliday (ryan.holliday@va.gov)
Acknowledgments Dr. Holliday’s work was supported in part by the Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs.
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner,Frontline Medical Communications Inc., the US Government, or any of its agencies.
Conclusion
Several PTSD-related factors might increase PB, TB, and the acquired capability for suicide among veterans with PTSD. Because suicide risk assessment and management can be time sensitive and anxiety provoking, mental health providers can use a TRM approach to increase their confidence in instituting optimal care and mitigating risk by having a structured, therapeutic assessment process that gathers appropriate suicide- and PTSD-related data to assist in developing suicide risk-related treatment. However, more research is needed to determine the most useful self-report measures and effective interventions when working with veterans with PTSD at risk of suicide.
